| Baba Abudu, MD | |
|
1400 W 4th St, Coffeyville, KS 67337-3306 | |
| (620) 251-1200 | |
| Not Available |
| Full Name | Baba Abudu |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 40 Years |
| Location | 1400 W 4th St, Coffeyville, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851449573 | NPI | - | NPPES |
| 057965 | Other | KS | BCBS |
| 10115630B | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 04-22583 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Coffeyville Regional Medical Center, Inc | Coffeyville, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Coffeyville Regional Medical Center, Inc. | 9032108865 | 22 |
News Archive
Together with colleagues from Sweden and Luxembourg, scientists from the Luxembourg Centre for Systems Biomedicine of the University of Luxembourg have observed that, during a natural vaginal birth, specific bacteria from the mother's gut are passed on to the baby and stimulate the baby's immune responses.
Interleukin Genetics, Inc. today announced that on November 1, 2010 notification was received that it has been awarded two grants totaling $473,393 by the United States Government under the Qualifying Therapeutic Discovery Project (QTDP) Program to advance the Company's genetic research projects related to obesity and osteoarthritis.
COVID-19 pandemic has shown the world that vaccines should be prioritised, writes Githinji Gitahi. Imagine a world in which everyone is at risk of contracting a contagious disease with no prevention or cure.
Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, today announced a new study has been published identifying the mechanism of action of the anti-cancer drug GMX1778. Co-authored by scientists at Gemin X Pharmaceuticals and Metabolon, the paper "The Small Molecule GMX1778 is a Potent Inhibitor of NAD+ Biosynthesis: Strategy for Enhanced Therapy in NAPRT1-Deficient Tumors" appears online ahead of print in Molecular and Cellular Biology.
› Verified 5 days ago
| Entity Name | Coffeyville Regional Medical Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265550891 PECOS PAC ID: 9032108865 Enrollment ID: O20040507000813 |
News Archive
Together with colleagues from Sweden and Luxembourg, scientists from the Luxembourg Centre for Systems Biomedicine of the University of Luxembourg have observed that, during a natural vaginal birth, specific bacteria from the mother's gut are passed on to the baby and stimulate the baby's immune responses.
Interleukin Genetics, Inc. today announced that on November 1, 2010 notification was received that it has been awarded two grants totaling $473,393 by the United States Government under the Qualifying Therapeutic Discovery Project (QTDP) Program to advance the Company's genetic research projects related to obesity and osteoarthritis.
COVID-19 pandemic has shown the world that vaccines should be prioritised, writes Githinji Gitahi. Imagine a world in which everyone is at risk of contracting a contagious disease with no prevention or cure.
Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, today announced a new study has been published identifying the mechanism of action of the anti-cancer drug GMX1778. Co-authored by scientists at Gemin X Pharmaceuticals and Metabolon, the paper "The Small Molecule GMX1778 is a Potent Inhibitor of NAD+ Biosynthesis: Strategy for Enhanced Therapy in NAPRT1-Deficient Tumors" appears online ahead of print in Molecular and Cellular Biology.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Baba Abudu, MD Po Box 787, Coffeyville, KS 67337-0787 Ph: (316) 685-8428 | Baba Abudu, MD 1400 W 4th St, Coffeyville, KS 67337-3306 Ph: (620) 251-1200 |
News Archive
Together with colleagues from Sweden and Luxembourg, scientists from the Luxembourg Centre for Systems Biomedicine of the University of Luxembourg have observed that, during a natural vaginal birth, specific bacteria from the mother's gut are passed on to the baby and stimulate the baby's immune responses.
Interleukin Genetics, Inc. today announced that on November 1, 2010 notification was received that it has been awarded two grants totaling $473,393 by the United States Government under the Qualifying Therapeutic Discovery Project (QTDP) Program to advance the Company's genetic research projects related to obesity and osteoarthritis.
COVID-19 pandemic has shown the world that vaccines should be prioritised, writes Githinji Gitahi. Imagine a world in which everyone is at risk of contracting a contagious disease with no prevention or cure.
Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, today announced a new study has been published identifying the mechanism of action of the anti-cancer drug GMX1778. Co-authored by scientists at Gemin X Pharmaceuticals and Metabolon, the paper "The Small Molecule GMX1778 is a Potent Inhibitor of NAD+ Biosynthesis: Strategy for Enhanced Therapy in NAPRT1-Deficient Tumors" appears online ahead of print in Molecular and Cellular Biology.
› Verified 5 days ago